Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Modern treatment of lymphoedema I. Complex physical therapy: the first 200 australian limbs

Identifieur interne : 00D439 ( Main/Exploration ); précédent : 00D438; suivant : 00D440

Modern treatment of lymphoedema I. Complex physical therapy: the first 200 australian limbs

Auteurs : J. R. Casley-Smith [Canada] ; J. R. Casley-Smith

Source :

RBID : Pascal:93-0305110

Descripteurs français

English descriptors

Abstract

Complex Physical Therapy (CPT) is discussed and its principles outlined. CPT involves: 1. skin care, 2. a special lymphatic massage, 3. compression bandaging and (laler) garments, 4. special exercises which supplement the massage. CPT was used on 78 patients with postmastectomy lymphoedema (17 with Grade 1 and 61 with Grade 2). There were significant differences between the Grades. In the first four-week course the mean Grade 1 was reduced from 121% of normal to 107% (the mean change in the oedema was 103% of its initial value), and Grade 2 from 153% to 123% (with a mean change in oedema of 60%)


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Modern treatment of lymphoedema I. Complex physical therapy: the first 200 australian limbs</title>
<author>
<name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Univ. Adelaide, Henry Thomas lab.</s1>
<s2>Adelaide S. Aust.</s2>
<s3>CAN</s3>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Adelaide S. Aust.</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">93-0305110</idno>
<date when="1992">1992</date>
<idno type="stanalyst">PASCAL 93-0305110 INIST</idno>
<idno type="RBID">Pascal:93-0305110</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D64</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000D44</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000D71</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000D71</idno>
<idno type="wicri:doubleKey">0004-8380:1992:Casley Smith J:modern:treatment:of</idno>
<idno type="wicri:Area/Main/Merge">00DF41</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:93-0305111</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D63</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000D45</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000D70</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000D70</idno>
<idno type="wicri:doubleKey">0004-8380:1992:Casley Smith J:modern:treatment:of</idno>
<idno type="wicri:Area/Main/Merge">00DF40</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:1294054</idno>
<idno type="wicri:Area/PubMed/Corpus">005A24</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005A24</idno>
<idno type="wicri:Area/PubMed/Curation">005A24</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005A24</idno>
<idno type="wicri:Area/PubMed/Checkpoint">005A24</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005A24</idno>
<idno type="wicri:Area/Ncbi/Merge">000E65</idno>
<idno type="wicri:Area/Ncbi/Curation">000E65</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000E65</idno>
<idno type="wicri:doubleKey">0004-8380:1992:Casley Smith J:modern:treatment:of</idno>
<idno type="wicri:Area/Main/Merge">00DB73</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:1294055</idno>
<idno type="wicri:Area/PubMed/Corpus">005A23</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005A23</idno>
<idno type="wicri:Area/PubMed/Curation">005A23</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005A23</idno>
<idno type="wicri:Area/PubMed/Checkpoint">005A23</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005A23</idno>
<idno type="wicri:Area/Ncbi/Merge">000E66</idno>
<idno type="wicri:Area/Ncbi/Curation">000E66</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000E66</idno>
<idno type="wicri:doubleKey">0004-8380:1992:Casley Smith J:modern:treatment:of</idno>
<idno type="wicri:Area/Main/Merge">00DB72</idno>
<idno type="wicri:Area/Main/Curation">00D439</idno>
<idno type="wicri:Area/Main/Exploration">00D439</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Modern treatment of lymphoedema I. Complex physical therapy: the first 200 australian limbs</title>
<author>
<name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Univ. Adelaide, Henry Thomas lab.</s1>
<s2>Adelaide S. Aust.</s2>
<s3>CAN</s3>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Adelaide S. Aust.</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name>
</author>
</analytic>
<series>
<title level="j" type="main">Australasian journal of dermatology</title>
<title level="j" type="abbreviated">Australas. j. Dermatol.</title>
<idno type="ISSN">0004-8380</idno>
<imprint>
<date when="1992">1992</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Australasian journal of dermatology</title>
<title level="j" type="abbreviated">Australas. j. Dermatol.</title>
<idno type="ISSN">0004-8380</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Administration, Cutaneous</term>
<term>Administration, Oral</term>
<term>Anticoagulants (therapeutic use)</term>
<term>Arm</term>
<term>Australia</term>
<term>Chemotherapy</term>
<term>China</term>
<term>Combined Modality Therapy</term>
<term>Compressive bandage</term>
<term>Coumarine derivatives</term>
<term>Coumarins (therapeutic use)</term>
<term>Double-Blind Method</term>
<term>Elephantiasis (drug therapy)</term>
<term>Elephantiasis (therapy)</term>
<term>Female</term>
<term>Flavonoid</term>
<term>Human</term>
<term>Humans</term>
<term>Hydroxyethylrutoside (analogs & derivatives)</term>
<term>Hydroxyethylrutoside (therapeutic use)</term>
<term>India</term>
<term>Leg</term>
<term>Limb</term>
<term>Lymphedema</term>
<term>Lymphedema (drug therapy)</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (therapy)</term>
<term>Male</term>
<term>Massage</term>
<term>Middle Aged</term>
<term>Multicenter Studies as Topic</term>
<term>Physical Therapy Modalities</term>
<term>Physical Therapy Modalities (methods)</term>
<term>Physical dressing</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Review</term>
<term>Rutoside</term>
<term>Time Factors</term>
<term>Treatment</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Administration par voie cutanée</term>
<term>Administration par voie orale</term>
<term>Adulte d'âge moyen</term>
<term>Anticoagulants (usage thérapeutique)</term>
<term>Association thérapeutique</term>
<term>Australie</term>
<term>Bras</term>
<term>Chine</term>
<term>Coumarines (usage thérapeutique)</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Inde</term>
<term>Jambe</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (traitement médicamenteux)</term>
<term>Lymphoedème (étiologie)</term>
<term>Mâle</term>
<term>Méthode en double aveugle</term>
<term>O-(bêta-Hydroxyéthyl)rutosides (analogues et dérivés)</term>
<term>O-(bêta-Hydroxyéthyl)rutosides (usage thérapeutique)</term>
<term>Techniques de physiothérapie</term>
<term>Techniques de physiothérapie ()</term>
<term>Éléphantiasis ()</term>
<term>Éléphantiasis (traitement médicamenteux)</term>
<term>Études multicentriques comme sujet</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Hydroxyethylrutoside</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Anticoagulants</term>
<term>Coumarins</term>
<term>Hydroxyethylrutoside</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Australia</term>
<term>China</term>
<term>India</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr">
<term>O-(bêta-Hydroxyéthyl)rutosides</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Elephantiasis</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Physical Therapy Modalities</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Elephantiasis</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Lymphoedème</term>
<term>Éléphantiasis</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Anticoagulants</term>
<term>Coumarines</term>
<term>O-(bêta-Hydroxyéthyl)rutosides</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Administration, Cutaneous</term>
<term>Administration, Oral</term>
<term>Arm</term>
<term>Combined Modality Therapy</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Humans</term>
<term>Leg</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Multicenter Studies as Topic</term>
<term>Physical Therapy Modalities</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Administration par voie cutanée</term>
<term>Administration par voie orale</term>
<term>Adulte d'âge moyen</term>
<term>Article synthèse</term>
<term>Association thérapeutique</term>
<term>Australie</term>
<term>Bras</term>
<term>Chimiothérapie</term>
<term>Chine</term>
<term>Coumarine dérivé</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Flavonoïde</term>
<term>Homme</term>
<term>Humains</term>
<term>Inde</term>
<term>Jambe</term>
<term>Lymphoedème</term>
<term>Membre</term>
<term>Bandage compressif</term>
<term>Massage</term>
<term>Australie</term>
<term>Homme</term>
<term>Mâle</term>
<term>Méthode en double aveugle</term>
<term>Rutoside</term>
<term>Techniques de physiothérapie</term>
<term>Traitement</term>
<term>Traitement physique</term>
<term>benzo pyrone derive</term>
<term>Éléphantiasis</term>
<term>Études multicentriques comme sujet</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Australie</term>
<term>Inde</term>
<term>République populaire de Chine</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Complex Physical Therapy (CPT) is discussed and its principles outlined. CPT involves: 1. skin care, 2. a special lymphatic massage, 3. compression bandaging and (laler) garments, 4. special exercises which supplement the massage. CPT was used on 78 patients with postmastectomy lymphoedema (17 with Grade 1 and 61 with Grade 2). There were significant differences between the Grades. In the first four-week course the mean Grade 1 was reduced from 121% of normal to 107% (the mean change in the oedema was 103% of its initial value), and Grade 2 from 153% to 123% (with a mean change in oedema of 60%)</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name>
</noCountry>
<country name="Canada">
<noRegion>
<name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00D439 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00D439 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:93-0305110
   |texte=   Modern treatment of lymphoedema I. Complex physical therapy: the first 200 australian limbs
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024